Xtx Topco LTD Solid Biosciences Inc. Transaction History

Xtx Topco LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $85,035 - $245,217	-197,756 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.74 - $1.79 $124,881 - $302,078	168,759 Added 581.99%	197,756 $237,000
Q4 2021 Feb 11, 2022	BUY	$1.69 - $2.46 $25,505 - $37,126	15,092 Added 108.54%	28,997 $51,000
Q3 2021 Nov 12, 2021	BUY	$2.38 - $3.77 $2,727 - $4,320	1,146 Added 8.98%	13,905 $33,000
Q2 2021 Aug 12, 2021	BUY	$3.49 - $5.51 $44,528 - $70,302	12,759 New	12,759 $47,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.